Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8‑K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 193
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated March 5, 2026 relating to REGENXBIO Inc.’s financial results.